Keeping Up with COVID

New information on the industry response to the pandemic is arriving at a fast and furious pace. The following links are provided to help you keep up to date:

 

Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine; Phase 3 to Begin in Late July  https://investors.modernatx.com/news-releases/news-release-details/moderna-completes-enrollment-phase-2-study-its-mrna-vaccine

 

Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s Vaccine Candidate https://investors.modernatx.com/news-releases/news-release-details/moderna-and-rovi-announce-collaboration-ous-fill-finish

 

Sanofi and Regeneron Provide Update on Kevzara Phase 3 Trial in COVID-19 Patients

https://www.sanofigenzyme.com/en/about-us/newsroom/2020/2020-07-02-20-30-00

 

GSK and Medicago Announce Collaboration to Develop a Novel Adjuvanted Vaccine Candidate  https://www.gsk.com/en-gb/media/press-releases/gsk-and-medicago-announce-collaboration-to-develop-a-novel-adjuvanted-covid-19-candidate-vaccine/

 

Pfizer and BioNTech Granted FDA Fast Track Designation for mRNA Vaccine Candidates https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-granted-fda-fast-track-designation-two

 

Gilead Presents Additional Data on Remdesivir for the Treatment of COVID-19

https://www.gilead.com/news-and-press/press-room/press-releases/2020/7/gilead-presents-additional-data-on-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19

 

Junshi Biosciences and Lonza Partner to Produce a Neutralizing Antibody Tackling COVID-19

https://www.lonza.com/news/2020-07-13-13-00

 

Regeneron Announces Manufacturing and Supply Agreement for Regn-Cov2 Anti-Viral Antibody Cocktail https://newsroom.regeneron.com/index.php/news-releases/news-release-details/regeneron-announces-manufacturing-and-supply-agreement-barda-and

 

NIH Launches Clinical Trials Network for COVID-19 Vaccines and Other Prevention Tools https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trials-network-test-covid-19-vaccines-other-prevention-tools

 

Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-signs-five-year-agreement-large-scale-drug

 

Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin with DOD Funding https://investors.emergentbiosolutions.com/news-releases/news-release-details/mount-sinai-health-system-emergent-biosolutions-and-immunotek

 

Novavax Announces $1.6 Billion Funding from Operation Warp Speed http://ir.novavax.com/news-releases/news-release-details/novavax-announces-16-billion-funding-operation-warp-speed

 

CDMO AGC Biologics and Molecular Partners AG to Develop Antiviral for COVID-19 https://www.agcbio.com/resource-center/news/agc-biologics-collaborates-with-molecular-partners-ag-to-develop-anti-covid-19-darpin-program